A Win For RayzeBio Inc.
Tue, Dec 26, 2023 at 07:06 PM
RayzeBio Inc. (RYZB:NASDAQ) soared at $61.4, a gain of 100.9%. On Tue, Dec 26, 2023, RYZB:NASDAQ hit a New 2-Week High of $61.4. The stock got featured on our News Catalysts scanner on Tue, Dec 26, 2023 at 05:34 PM in the 'ACQUISITION' category. From Wed, Dec 13, 2023, the stock recorded 75.00% Up Days and 66.67% Green Days
About RayzeBio Inc. (RYZB:NASDAQ)
RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 222.58%
- ARB IOT Group Limited (ARBB:NASDAQ), 175.53%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 175%
- Baudax Bio, Inc. (BXRX:NASDAQ), 139.88%
- RayzeBio Inc. (RYZB:NASDAQ), 100.85%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 80.87%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 62.14%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 60.26%
- Sight Sciences Inc. (SGHT:NASDAQ), 46.7%